Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Minesto publishes Half-Year Report 2023

CEO Dr Martin Edlund:” With the second quarter, we further accelerate our focus on driving large-scale, project-based sales of tidal energy arrays, where reference installations of our smaller power plant Dragon 4 are the key to long term business.”Significant events April-June 2023 At the end of May, Minesto initiated the installation of the first megawatt-unit, Dragon 12 (1.2 MW). The first phase of the offshore installation of Dragon 12 was successfully completed in Vestmanna, Faroe Islands. The 3.4 km main subsea cable was laid on the seabed, from the onshore grid connection point to

Wyld Networks brings forward publication of financial report for Q2 2023

Publication of Wyld Networks report for the second quarter will be brought forward to August 21, 2023. The previously announced date for publication was August 30, 2023.The reason why the company is bringing forward the financial report is that the financial statements will be ready faster than expected and that the Board therefore sees no reason to delay publication.   For further information about Wyld Networks, please contact: Alastair Williamson, CEO Wyld NetworksE-mail: alastair.williamson@wyldnetworks.comTel: +44 7 824 997 689   About Wyld Networks Wyld Networks

ORGANOCLICK AB (PUBL) PUBLISH INTERIM REPORT FOR Q2 2023

"Our strategic transformation to become a chemical company has continued according to plan during the second quarter. Binder sales in Nonwoven & fiber technologies continued to grow sharply, and our consumer products in Green coatings & maintenance products also showed good growth. On the other hand, sales of OrganoWood timber in Functional wood dropped heavily because of the weak construction activity. All in all, the group’s sales grew by 6 percent to MSEK 41.0 (38.5)."Translation from CEO Mårten Hellbergs comments to the Interim Report. Q2, 1 April - 30 June 2023 The Group compared

Jacob Lund joins Investor as Head of Corporate Communication & Sustainability

Jacob Lund, currently Head of Global Media Relations at AstraZeneca, has been appointed new Head of Corporate Communication & Sustainability and member of the Executive Leadership Team at Investor. Jacob has most recently worked for ten years at AstraZeneca where he has held several leading communication positions including Head of Chair Office, Head of Corporate Affairs Sweden & Nordics and Head of Corporate Affairs Global Sustainability. He has also been a member of AstraZeneca’s Global Sustainability leadership team. Before joining AstraZeneca, Jacob led the Media practice in Sweden at

TORM plc Q2 2023 results, dividend distribution, and financial outlook 2023

“During the second quarter of 2023, we experienced a continued healthy rate environment, contributing to a profit before tax of USD 184m compared to USD 107m in the same period last year,” says Jacob Meldgaard and continues: “Based on this, we will return USD 126.6m to our shareholders as dividends for the period.” Financial results In the second quarter of 2023, TORM saw a 23% increase in TCE per day to 36,360 USD/day (2022, same period: 29,622 USD per day) as a result of higher freight rates. TCE earnings reached USD 308.0m (2022, same period; USD 209.6m) and EBITDA increased 54% to

BioStock: Neola CEO sees exciting autumn ahead

As Neola Medical reports its second quarter of 2023, much of the focus is on market preparations. Intensive work is underway with technical verification studies while the company is also preparing for both a preclinical and a clinical study. BioStock contacted CEO Hanna Sjöström to find out more about how she views the development during the quarter.Read the full article at biostock.se : https://www.biostock.se/en/2023/08/neola-ceo-sees-exciting-autumn-ahead/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nordea cancels repurchased shares

Nordea Bank AbpStock exchange release – Total number of voting rights and capital17 August 2023 at 9.15 EET Nordea has today cancelled 9,635,610 treasury shares in line with the decision by the Board of Directors. The shares were held for capital optimisation purposes and acquired through share buy-backs. The cancellation brings the total number of shares in Nordea to 3,569,745,018. The total number of votes attached to the shares is 3,569,745,018. The cancellation of the shares was registered with the Finnish Trade Register on 17 August 2023. The company holds 1,976,528

Dignitana AB Publishes Q2 2023 Interim Report

15 percent revenue growth driven by improved utilization Financial highlights Q2 2023 · Net sales amounted to 21.1 MSEK (18.3), an increase of 15 percent over the same period in 2022 · Operating result amounted to -4.7 MSEK (+0.1). · Net result after financial items amounted to -4.7 MSEK (-0.2). · Earnings per share were-0.07 SEK (0.00). · Cash Balance amounted to 5.4 MSEK (7.3). · Average Daily Treatment Revenue (ADTR)* was 241 TSEK (201), an increase of 20 percent over the same period in 2022. Business highlights during the period · Dignitana announced a

Penneo achieves 25% year-on-year ARR growth in H1-2023

Company Announcement No. 27-2023Copenhagen, 17 August 2023Interim financial report for the period 1 January 2023 - 30 June 2023H1-2023 performance highlights · ARR increased by 8.3M DKK to 79.2M DKK corresponding to 25% year-on-year (YoY) growth at the end of the quarter · ARR increase from Newbiz amounted to 4.3M DKK compared to 4.8M DKK in H1-2022 · ARR increase from Uplift amounted to 5.3M DKK compared to 4.0M DKK in H1-2022 · ARR lost to Churn amounted to 1.2M DKK compared to 0.7M DKK in H1-2022 · ARR from foreign markets increased by 2.4M DKK compared to 3.3M DKK

AnaCardio receives IND approval from the FDA for AC01 to Start a Clinical Pharmacology Study

PRESS RELEASE Stockholm, Sweden, August 17, 2023AnaCardio, a Swedish clinical-stage biopharmaceutical company focussing on developing novel contractile agents to treat patients with heart failure, today announced that the U.S. Food and Drug Administration (FDA) has granted the company's Investigational New Drug (IND) application for the investigational drug AC01. The approval enables expansion of the clinical development program for AC01 to the US, and to initiate a study in healthy volunteers. This study will evaluate the effects of food on the pharmacokinetics of orally administered

Interim Report for 2nd Quarter 2023

Revenues increased 37% and EBIT increased 208%Key Facts for the 2[nd] Quarter 2023 (1[st] April 2023 – 30[th] June 2023) Revenues increased 37% and EBIT increased 208% All figures are compared to the same quarter last year if not explicitly stated otherwise. · Revenues increased by 36.54% to €9,458,630 (€6,927,414). · EBIT increased by 207.95% to €676,489 (-€626,662). · EBIT margin of 7.15% (-9.05%). · Customer deposits increased by 16.35% to €17,688,865 (€15,202,758). · 30,990 new registered customers (91,142), decrease of 66%. · 9,646 new depositing customers (14,

FlashBet App Rights Acquisition and Equity Issue

17 August 2023 ChallengerX plc                                                            (“ChallengerX”, “CXS" or the Company") FlashBet App Rights Acquisition and Equity Issue ChallengerX  (AQUIS: CXS), the company that employs both traditional and non-traditional marketing strategies to rapidly “professionalise” amateur and semi-professional sports clubs around the world, is pleased to announce that it has entered into an exclusive licence agreement with Flash Corp Technologies Ltd (“Flash Corp”) by which the Company has acquired a renewable 13-month license over the rights

NoHo Partners closes transaction to acquire the Swiss premium burger chain Holy Cow!

NoHo Partners Plc INVESTOR NEWS 17 AUGUST 2023 at 09:00 EET   On 6 July 2023, NoHo Partners announced that it establishes Better Burger Society, a company targeting a leading position in the growing premium burger market in Europe, together with an equity investor. The first acquisition of Better Burger Society is the Swiss premium burger chain Holy Cow!. The approval by the Finnish competition authorities, which the transaction was conditional to, has been received and the transaction was closed on 14 August 2023. Holy Cow!’s figures will be consolidated as part of the Group’s

Fractal Gaming Group Interim Report January-Jun 2023

Second quarter 2023 · Net sales amounted to SEK 245.3 million (95.4). · Product profit amounted to SEK 98.7 million (29.3), with a product margin of 40.2% (30.7). · EBITDA amounted to SEK 47.9 million (-3.0), corresponding to an EBITDA margin of 19.5% (-3.2). · EBIT amounted to SEK 42.7 million (-7.5), corresponding to an EBIT margin of 17.4% (-7.9). · Operating cash flow amounted to SEK 64.0 million (-7.7). · Interest-bearing net debt was SEK -12.7 million (127.4). · Earnings per share amounted to SEK 1.2 (-0.1). · No items affecting comparability for the quarter.

Orthex’s Half-year financial report and invitation to the result presentation on 24 August 2023

Orthex Corporation, Press release, 17 August 2023 at 9.00 a.m. EESTOrthex will publish its Half-year financial report for the period January−June 2023 on Thursday, 24 August 2023 at around 9.00 a.m. EEST. Following the publication, the report will be available in pdf-format on the corporate website https://investors.orthexgroup.com/.Orthex’s CEO Alexander Rosenlew, CFO Saara Mäkelä and CMO Hanna Kukkonen will present the report on the same day at 11.00 a.m. EEST in a webcast. The webcast can be joined through this link . The webcast

Sivers Semiconductors AB (publ), publishes Interim Report Q2, January – June 2023 and confirm outlook for 2023

91 percent growth year-to-date - confirming 100 % growth out­lookOutlook for 2023Previously announced customer contracts are expected to drive significant net sales growth for Sivers in 2023. Continuous optimization of costs and investments, together with net sales growth, are expected to accelerate Sivers’ path to profitability.For 2023 Sivers expects net sales growth to exceed 100% over 2022. Net sales may vary between quarters as a result of individual contracts. Furthermore, Sivers expects to reach positive adjusted EBITDA in the second half of 2023. Second quarter April-June

Caverion to modernise the Fingrid substation in Kajaani, Finland – Promotes operational reliability as power transmission increases

Caverion Corporation Investor news 17 August 2023 at 9:00 a.m. EESTCaverion to modernise the Fingrid substation in Kajaani, Finland – Promotes operational reliability as power transmission increases Fingrid has chosen Caverion as its contractor for the modernisation of the Vuolijoki substation in Kajaani, Finland. The modernisation will improve the substation’s operational reliability as power transmission increases. The project includes the expansion of the current 400 kV and 110 kV assembly and the renewal of the safety and control system. The total value of the agreement is

Interim report January–June 2023

Continued strong earnings despite challenging conditionsOn a year-on-year basis, net operating income increased 6% and EBITDA increased 11% in the period from January to June 2023. This was despite high inflationary pressure and, following completed divestments, a slightly smaller property portfolio. As a result of rising interest expenses, income from property management per share declined 38%. The value change in the property portfolio amounted to a decline of 0.5% for the quarter, primarily due to raised yield requirements, which were partially offset by ongoing efficiency

Odfjell first to install suction sails on deep-sea chemical tanker

In partnership with bound4blue, a pioneering developer of wind-assisted propulsion technology, Odfjell will install the innovative eSAIL® system on a chemical tanker, making it the first tanker vessel in the world to harness this ground-breaking technology.bound4blue’s eSAIL® system utilizes a cutting-edge wind-assisted propulsion system known as a suction sail. By promoting the use of wind power to propel vessels, this technology significantly reduces fuel consumption and pollutant emissions. Odfjell has actively pursued decarbonization initiatives for many years, and recently

Interim Report Second Quarter 2023

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO STENOCARE A/S (“STENOCARE”) today announces its results for the period 01.01.2023 – 30.06.2023. The report, which has not been reviewed by the Company’s auditors, is attached to this release and is also available on https://stenocare.com/investor-relations/Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments: ” Stenocare reached several milestones during Q2 2023 and realized sales of 1.7 mDKK. A UK industry journalist called it a “swathe of updates”, referring to our entry into Germany, launch of an Online

Prostatype Genomics presents Quarterly Report

Prostatype Genomics AB has today published its quarterly report for the second quarter comprising the period from 1 April 2023 to 30 June 2023. The Company also projects that revenue growth will return to positive trend in the Third Quarter. The report is available on the company website .Quarter 2 (1 April – 30 June 2023) summarized · Net sales amounted to 56 TSEK. · Net revenue amounted to 56 TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -9 587 TSEK. · Cash flow from current operations in the

Karnov Group reports second quarter results 2023

Strong growth and progress in integrationFinancial highlights second quarter · Organic growth (constant currency) was 8.2% in the quarter. The Group’s net sales increased by 167.6% to SEK 608 m (actual 227 proforma* 549). Acquired growth contributed with 154.5%. Currency effect was 4.9%. Net sales in Region North were SEK 259 m (227) and net sales in Region South were SEK 349 m (proforma* 321) · The Group’s adjusted EBITA amounted to SEK 109 m (actual 74, proforma* 101) with adjusted EBITA margin of 18.0% (actual 32.6%, proforma 18.4%). Region North contributed with SEK 103 m (88),

Interim report Q2: Strong cash flow and advanced positions in the mining industry

April – June 2023 · Net sales were in line with previous year and amounted to SEK 907 (911) million · Organic growth amounted to -10 (25) % · Adjusted EBIT amounted to SEK 71 (74) million with a margin of 7.8 (8.2) % · Cash flow from operating activities increased to SEK 101 (-9) million · Earnings per share for the period before and after dilution amounted to SEK 0.72 (0.78) "The second quarter has been marked by continued strong general demand for our infrastructure services, while the decline in construction of new housing has had a negative impact. Net sales for the

Neogap winner of Business Sweden’s Catalyst Program

Swedish biotechnology company Neogap Therapeutics has been selected winner of Business Sweden’s Catalyst Program 2023. Neogap will gain a powerful stepping stone towards international growth, including a tailored market entry project worth SEK 250,000 to support and accelerate its international growth journey.Neogap Therapeutics has been awarded as one of three winners of Business Sweden’s Catalyst Program 2023 in the category of Deep Tech. Business Sweden’s Catalyst Program is a scale-up program for Sweden’s most innovative and promising companies. Candidates that successfully make it

There are no items matching the current filter
There are no more items matching the current filter
Back to top